Literature DB >> 1323859

The cocaine experience: refuting the concept of a model psychosis?

S B Unnithan1, J C Cutting.   

Abstract

Eighteen patients admitted to a drug dependency unit for opiate detoxification and who had recently used cocaine were asked to describe the experience based on a questionnaire. A comparison was made with 18 schizophrenic patients who completed the same questionnaire. Results showed a qualitative difference in the subjective phenomena described by the two groups. There appeared to be certain phenomena present in a cocaine induced state which appear to be specific to this state. Amongst these features are: increased intensity of colours, prominence of certain colours in illusions, i.e. red and green, and changes in light intensity. Objects appear to be more vivid and stand out, macropsia and micropsia also seem to occur in this group and paranoia if present is of a transient nature. These particular symptoms do not seem to be characteristic of a schizophrenic illness. This may therefore contradict the idea of a drug induced psychosis (in this case cocaine) as being indistinguishable from schizophrenia (the model psychosis theory).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323859     DOI: 10.1159/000284756

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  2 in total

1.  Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.

Authors:  Simon Zhornitsky; Emmanuel Stip; Joelle Desfossés; Tania Pampoulova; Elie Rizkallah; Pierre-Paul Rompré; Lahcen Aït Bentaleb; Olivier Lipp; Jean-Pierre Chiasson; Alain Gendron; Stéphane Potvin
Journal:  Front Psychiatry       Date:  2011-05-13       Impact factor: 4.157

Review 2.  Prevalence of alcohol and drug abuse in schizophrenic inpatients.

Authors:  M Soyka; M Albus; N Kathmann; A Finelli; S Hofstetter; R Holzbach; B Immler; P Sand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.